Akademisyen
ŞİFA ŞAHİN
DOKTOR ÖĞRETİM ÜYESİ
AFYONKARAHİSAR SAĞLIK BİLİMLERİ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Çocuk Hematolojisi ve Onkolojisi (Çocuk Sağlığı ve Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 35
- Proje 0
- Kitap 94
- Bildiri 82
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
7
Q2
3
Q3
9
Q4
1
WoS (JCR)
Q1
7
Q2
0
Q3
6
Q4
11
TR Index
13
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
4
Ort. yüzdelik
46.5%
Üst %1 payı
0.0%
Üst %10 payı
14.8%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 If you involve me I learn: responsibility-integrated task-based education (RITBE) model in medical intern training YÖKSİS SJR Q1 JCR Q1 OpenAlex 42.7%
- 2026 Clinical Characteristics, Long-Term Outcomes, and Predictors of Chronicity in Pediatric Immune Thrombocytopenia YÖKSİS SJR Q3
- 2026 Olfactory assessment in treatment and survivor groups of pediatric solid malignancies YÖKSİS SJR Q2 JCR Q3 OpenAlex 34.9%
- 2026 Olfactory assessment in treatment and survivor groups of pediatric solid malignancies YÖKSİS SJR Q2 JCR Q3
- 2026 Improving time to antibiotic administration in febrile neutropenia: A quality improvement initiative in a pediatric oncology inpatient unit YÖKSİS TR Index
- 2025 Challenges in hemoglobinopathy control programs: Insights from Türkiye YÖKSİS SJR Q1 JCR Q1
- 2025 Three locally invasive infantile fibrosarcoma cases treated with larotrectinib YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 77.8%
- 2025 Three locally invasive infantile fibrosarcoma cases treated with larotrectinib YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 77.8%
- 2025 Locally Invasive Infantile Fibrosarcoma: Larotrectinib Experience in Three Cases YÖKSİS TR Index SJR Q3 JCR Q3
- 2025 Clinical Presentation, Treatment, and Outcomes of Pediatric Brain Tumors: A 5-Year Single-Center Experience in Istanbul YÖKSİS OpenAlex 60.5%
- 2025 Challenges in hemoglobinopathy control programs: Insights from Türkiye YÖKSİS SJR Q1 JCR Q1
- 2025 Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.9%
- 2025 Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.9%
- 2025 Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.9%
- 2025 Three locally invasive infantile fibrosarcoma cases treated with larotrectinib YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 77.4%
- 2025 Diffuse Large B-Cell Lymphoma Developed in the Context of Primary Immunodeficiency YÖKSİS SJR Q3 JCR Q4
- 2024 Clinical Presentation, Treatment, and Outcomes of Pediatric Brain Tumors: A 5-Year Single-Center Experience in Istanbul YÖKSİS SJR Q3 JCR Q4 OpenAlex 60.5%
- 2024 Clinical Presentation, Treatment, and Outcomes of Pediatric Brain Tumors: A 5-Year Single-Center Experience in Istanbul YÖKSİS SJR Q3 JCR Q4 OpenAlex 60.5%
- 2024 Pregnancy in Patients with Thalassemia: A Single-Center Study YÖKSİS JCR Q4 OpenAlex 8.6%
- 2024 Pregnancy in Patients with Thalassemia: A Single-Center Study YÖKSİS JCR Q4 OpenAlex 8.6%